Odyssey Health (ODYY) Net Cash Flow Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Net Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -17.53% |
| Jan 31, 2026 | 35.53% |
| Oct 31, 2025 | -50.98% |
| Jul 31, 2025 | -15.23% |
| Apr 30, 2025 | -16.73% |
| Jan 31, 2025 | 14.06% |
| Oct 31, 2024 | 22.82% |
| Jul 31, 2024 | -18.95% |
| Apr 30, 2024 | -219.44% |
| Jan 31, 2024 | -142.82% |
| Oct 31, 2023 | 204.51% |
| Jul 31, 2023 | 52.30% |
| Apr 30, 2023 | -51.66% |
| Jan 31, 2023 | -5.74% |
| Oct 31, 2022 | -63.31% |
| Jul 31, 2022 | 81.91% |
| Apr 30, 2022 | 91.80% |
| Jan 31, 2022 | -116.64% |
| Oct 31, 2021 | -122.38% |
| Jul 31, 2021 | -167.74% |